What are the top 10 things you love most about the Pork Industry? Doug King, DVM from Merck Animal Health divulges his top 10, among other hot topics regarding their leading product portfolio

338

Get in the “Swineweb” with Merck Animal Health. An ingenious leader and innovator in Swine Health Doug King, DVM opens up about their Portfolio, what producers needs, and his top ten loves in the Pork Industry!

Question (Jim Eadie from Swineweb.com):
The hot stove in the field is that Merck Animal Health has the complete portfolio and that is hard to compete with. Can you explain the most unique attribute of your portfolio to help pork producers?

Answer (Doug King, DVM – a Swine Technical Service Veterinarian with Merck Animal Health):
The Merck Animal Health Swine product portfolio includes traditional vaccines such as Circumvent® G2, reproductive management products such as MATRIX® and P.G.600®, as well as customizable RNA particle (RP) vaccines within our SEQUIVITY™ platform. We focus on disease prevention, optimization of reproductive performance and provide RP vaccines for pathogens that are new or for pathogens not well suited for a commercial vaccine option. We strive to ensure our products allow pork producers have healthy pigs performing to their full biological potential.

Question (Jim Eadie from Swineweb.com):
I find customer service is the key to all business. How do you feel your veterinary services team excels at providing superior customer service and your thoughts on this intangible part of helping client?

Answer (Doug King, DVM – a Swine Technical Service Veterinarian with Merck Animal Health):
Veterinarians within the Merck Swine Technical Services team are directly involved with our customers. Within our team we have collectively over 200 years of experience in the swine industry. Most of our team has worked in swine production systems and understand the needs of the customer. Individuals within our team have specific areas of expertise such as disease related to Porcine Circovirus, reproduction topics, and sequence analysis for SEQUIVITY® RP vaccines. When our customers have challenges, we look at that as an opportunity to dig deeper with diagnostics to better understand the problem and work to provide solutions the get pigs on track to improved health and performance.

Question (Jim Eadie from Swineweb.com):
The future of animal health and innovation is changing with the wind. What is new and upcoming at Merck that we can expect?

Answer (Doug King, DVM – a Swine Technical Service Veterinarian with Merck Animal Health):
We continue to adapt to customers’ needs from vaccine innovation to technology. From a biosecurity perspective we recently started supplying a disinfectant with significant residual activity called Armatrex to swine producers. Within the Antelliq brand we are working to provide technology in swine barns that brings value to producers in the area of precision swine production such that pig’s health and growth can be monitored more proactively.

Question (Jim Eadie from Swineweb.com):
How has the Merck veterinarian services team supported producers during the COVID-19 pandemic?

Answer (Doug King, DVM – a Swine Technical Service Veterinarian with Merck Animal Health):
The effects of Covid-19 are far reaching. The swine industry was particularly impacted. Within Merck Animal Health we have worked to help swine producers dealing with mass euthanasia, been engaged in our communities in efforts like blood drives, and sponsored webinars such as Science Talks to remain engaged in the swine industry. We continue to work with individual customers over the phone or virtually via webinars or conference calls to help them as needed.

Question (Jim Eadie from Swineweb.com):
SEQUIVITY™ seems to be a focus for Merck the last few years. Explain to customers why this is so important to their operation?

Answer (Doug King, DVM – a Swine Technical Service Veterinarian with Merck Animal Health):
SEQUIVITY® RP vaccines provide a means whereby a vaccine can be created based on the genetic sequence of the pathogen from diagnostic lab submissions. Influenza viruses change frequently via genetic drift and genetic shift. To monitor changes in influenza viruses in pigs, Merck Animal Health has a database of customer viral sequences downloaded directly from diagnostic lab cases. By analyzing genetic sequences in our database, we can provide vaccines based on influenza strains in your pigs and strains in nearby pigs that may infect your herd. This is real time information used to update flu vaccines at timely intervals throughout the year. Rotavirus is another pathogen of increasing significance in pigs. Certain strains of Rotavirus such as Rotavirus Type C cannot be grown on cell culture as is commonly done to produce viral vaccines. SEQUIVITY® Technology allows us to produce a vaccine based on the Rotavirus gene sequence without having to cultivate the virus.

Question (Jim Eadie from Swineweb.com):
Over the last six months you have a pulse of challenges with herd Health, what is your summary on the most talked about subject?

Answer (Doug King, DVM – a Swine Technical Service Veterinarian with Merck Animal Health):
Unfortunately, during the last six months the swine industry faced overwhelming challenges such as dealing with Covid-19 with packing plants not running or running at reduced capacities and associated economic losses throughout the industry. This disruption has impacted Merck Animal Health as well. Initially we worked diligently to maintain our product supply chain and ensure our customers could acquire our products as needed. On a personal level we have learned to work with customers virtually and more recently have begun incorporating more farm visits and customer interactions in a safe manner.

Question (Jim Eadie from Swineweb.com):
Top 10 list. What are the top 10 things you love most about the Pork Industry?

Answer (Doug King, DVM – a Swine Technical Service Veterinarian with Merck Animal Health):

  1. The people
  2. Doing what’s best for the pig
  3. Continuous improvement
  4. Innovations to improve performance
  5. Leveraging use of technology
  6. Increasing biologic potential of pigs
  7. Staying vigilant against ASF introduction
  8. The U.S. is the best at producing pigs
  9. Export markets continue to grow
  10. Love eating Pork!

LEAVE A REPLY

Please enter your comment!
Please enter your name here